ImmunOs Therapeutics

formerly Immunos

Harnessing the Immune System to treat Cancer and Inflammatory Diseases - Immunostherapy

Basel, Switzerland · Founded 2014 · $102.5M raised

Headquarters
Basel
Employees
11–50
Founded
2014
Business Model
B2B
Total Funding
$102.5M
Last Round
$11.0M Series CSep 2024
Rounds
3

About

ImmunOs Therapeutics AG develops novel therapeutics that harness the immune system to treat cancer and inflammatory diseases. The company works from an HLA-based technology platform with programs spanning immuno-oncology and inflammatory-disease pipelines. Its team brings expertise in drug development and commercialization in immunology, immunotherapy, and oncology, and its stated mission is to develop novel therapeutics that improve the lives of patients with serious diseases.

Summary

ImmunOs Therapeutics is a Biotech company based in Basel, Switzerland, founded in 2014. It has raised $102.5M in total across 3 rounds, most recently a $11.0M Series C round in Sep 2024. Investors include Lightspeed Venture Partners, Gimv and Pfizer Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CSep 2024
$11.0M

Sign up to see all 3 rounds

Series A through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ImmunOs Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/immunos-therapeutics"><img src="https://indexed.vc/api/badge/company/immunos-therapeutics" alt="ImmunOs Therapeutics on Indexed.vc" width="260" height="76" /></a>